Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2027-09-20
Target enrollment:
Participant gender:
Summary
Metformin is an antidiabetic biguanide drug that acts by promoting glucose uptake and
utilization in the liver. Recent studies proved that metformin could reduce colonic
inflammation by AMPK-mediated inhibition of p38 mitogen-activated protein kinase (MAPK)